Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in April 2026 (Volume 30, Issue 1) Submit manuscript

Case report of Paraproteinemia

Breadcrumb

  • Home
  • Case report of Paraproteinemia

Janardhan DC *, Pramod K, Praveen Kumar and Basavarajaiah DM

Department of Neurology, BMCRI Super Specialty Hospital/PMSSY Hospital, Bengalore, Karnataka, India.
 
Case Study
World Journal of Advanced Research and Reviews, 2022, 16(02), 848-850
Article DOI: 10.30574/wjarr.2022.16.2.0771
DOI url: https://doi.org/10.30574/wjarr.2022.16.2.0771
 
Received on 26 July 20212 revised on 18 November 2022; accepted on 20 November 2022
 
Different peripheral neuropathies are linked to paraproteinemia. Anti-myelin-associated glycoprotein (MAG) neuropathy, immunoglobulin or its fragment deposition in the interstitium, immunoglobulin light chain amyloidosis (AL amyloidosis) and paraneoplastic mechanisms that cannot be solely attributed to immunoglobulin or its fragment deposition, represented by polyneuropathy, organotypic, are the three main causes of neuropathy correlated with paraproteinemia. Nerve conduction metrics slow down in patients with POEMS syndrome and anti-MAG neuropathy. An approximately (3.2%) of people over the age of 45-50 have paraproteins in their bodies. Plasma cell diseases can be thought of as a continuum of illnesses ranging from asymptomatic myeloma to symptomatic monoclonal gammopathy of unknown significance (MGUS). A low amount of paraprotein (30 g/L), a low percentage of plasma cells in the bone marrow, and the absence of organ or tissue damage from myeloma are the characteristics of MGUS (predominantly renal, skeletal or bone marrow impairment.) No treatment is necessary for MGUS, and there is a 1% annual risk.
 
Paraproteinemia; POEMS; anti-MAG neuropathy; MGUS
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2022-0771.pdf

Preview Article PDF

Janardhan DC, Pramod K, Praveen Kumar and Basavarajaiah DM. Case report of Paraproteinemia. World Journal of Advanced Research and Reviews, 2022, 16(2), 848-850. Article DOI: https://doi.org/10.30574/wjarr.2022.16.2.0771

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution